Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Nightly use of 0 ...

The FDA declined to approve SYD-101, a low-dose atropine formulation that would have been the first pharmaceutical treatment for slowing the progression of pediatric myopia in the U.S., according to a ...

Please provide your email address to receive an email when new articles are posted on . Both 0.03% and 0.05% atropine eyedrops significantly enlarged pupil size. Low-dose atropine drops had no ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.

Prior to this research, recent trials conducted primarily in East Asia showed a benefit from .01 percent atropine in slowing myopia. The randomized controlled trial, conducted by the Pediatric Eye ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...

Background: Many efforts have been invested in slowing progression of myopia. Among the methods, atropine administration and orthokeratology (OK) are most widely used. This study analyzed the efficacy ...

UAB School of Optometry professor is joining a national network study to research myopia prevention in children. Myopia, ...

Myopia, or nearsightedness, is an increasingly common eye condition that causes distant objects to appear blurry, often requiring corrective lenses. As the medical director of ophthalmology at ...